Trop molecules as targets for anti-tumor immunotherapy in man

Tumori

Volumn 87, Issue 6, 2001, Pages

  Alberti, Saverio ^a  

^a Laboratorio Angela Valenti dei Fattori Genetici e Ambientali di Rischio Trombotico   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; PROTEIN TROP; UNCLASSIFIED DRUG; CELL SURFACE PROTEIN; EDRECOLOMAB; GLYCOPROTEIN; TROP 1 PROTEIN; TROP 2 PROTEIN;

CANCER IMMUNOTHERAPY; CARCINOGENESIS; CELL ADHESION; CONFERENCE PAPER; IMMUNIZATION; PROTEIN STRUCTURE; ARTICLE; BASAL CELL CARCINOMA; BLADDER CARCINOMA; BREAST CARCINOMA; CHORIOCARCINOMA; COLON CANCER; COLON CARCINOMA; DRUG TARGETING; ENDOMETRIUM CARCINOMA; ESOPHAGUS CARCINOMA; HUMAN; KIDNEY CARCINOMA; LUNG ADENOCARCINOMA; MALE; NONHUMAN; OVARY CARCINOMA; PANCREAS CARCINOMA; PROSTATE CARCINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; SQUAMOUS CELL LUNG CARCINOMA; SQUAMOUS CELL SKIN CARCINOMA; STOMACH CARCINOMA; TERATOCARCINOMA; TUMOR IMMUNOLOGY; VERRUCA VULGARIS;

EID: 0035746630     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160108700628     Document Type: Conference Paper

References (38)

1. Therapeutic vaccination for cancer
2. Colorectal carcinoma antigens detected by hybridoma antibodies
3. Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells
4. Efficient selection of human tumor growth-inhibiting monoclonal antibodies
5. Epidermal growth factor receptor inhibition by a monoclonal antibody as anticancer therapy
6. Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma
7. Monoclonal antibodies in the clinic
8. Retroposition in a family of carcinoma-associated antigen genes
9. Biochemical characterization of Trop-2, a cell surface molecule expressed by human carcinomas: Formal proof that the monoclonal antibodies T16 and MOv-16 recognize Trop-2
10. Specificity and properties of mab RS7-3G11 and the antigen defined by this pancarcinoma monoclonal antibody
11. Characterization of cluster 13: The epithelial/carcinoma antigen recognized by MAb RS7
12. Cell-surface antigens of human bladder cancer defined by mouse monoclonal antibodies
13. Human trophoblast cell-surface antigens defined by monoclonal antibodies
14. Expression of 38-kD cell-surface glycoprotein in transformed human keratinocyte cell lines, basal cell carcinomas, and epithelial germs
15. Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearence of markers for terminal differentiation
16. Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins
17. Epidermal growth factor-like repeats mediate lateral and reciprocal interactions of Ep-CAM molecules in homophilic adhesions
18. Cloning of the gene encoding Trop-2, a cell-surface glycoprotein expressed by human carcinomas
19. Cloning of the mouse Trop2 gene-conservation of a PIP2-binding sequence in the cytoplasmic domain of Trop-2
20. Sequence investigation of the major gastrointestinal tumor-associated antigen gene family, GA733
21. Biochemical and immunological characterization of the human carcinoma-associated antigen MH 99/KS 1/4
22. Metastasis-association of the rat ortholog of the human epithelial glycoprotein antigen EGP314
23. The epithelial/carcinoma antigen EGP-1, recognized by monoclonal antibody RS7-3G11, is phosphorylated on serine 303
24. Large and diverse numbers of human diseases with HIKE mutations
25. The human Trop-2 is a tumor-associated calcium signal transducer
26. Assignment of TACSTD1 (alias TROPI, M4S1) to human chromosome 2p21 and refinement of mapping of TACSTD2 (alias Trop-2, M1S1) to human chromosome 1p32 by in situ hybridization
27. DNA methylation prevents transfection of genes for specific surface antigenes
28. DNA methylation prevents the amplification of Trop-1, a tumor associated cell surface antigen gene
29. Recurrent chromosome aberrations in cancer
30. Identification of the gene responsible for gelatinous drop-like corneal dystrophy
31. Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma
32. Therapy of colorectal carcinoma with monoclonal antibodies (MAb 17-1A) alone and in combination with granulocyte monocyte-colony stimulating factor (GM-CSF)
33. Initial clinical evaluation of two murine IgG2a monoclonal antibodies for immunotherapy of gastrointestinal carcinoma
34. The epithelial glycoprotein 2 (EGP-2) promoter-driven epithelial-specific expression of EGP-2 in transgenic mice: A new model to study carcinoma-directed immunotherapy
35. Humanized antibodies for therapy
36. Antibody engineering at the millennium
37. Recombinant Fv immunotoxins and Fv fragments as novel agents for cancer therapy and diagnosis
38. Three-step radioimmunotherapy with yttrium-90 biotin: Dosimetry and pharmacokinetics in cancer patients